Alberto Ascherio

Alberto Ascherio

professor United States

Alberto Ascherio is a prominent epidemiologist at Harvard University, known for his research in the fields of infectious diseases and neurological disorders. His work has contributed significantly to understanding the links between viral infections and the development of conditions such as Alzheimer's disease. In a recent study regarding the effects of the herpes zoster vaccine on dementia risk, Ascherio expressed optimism about the findings, highlighting the need for further research to explore potential public health implications.

Born on Jan 01, 1950 (75 years old)

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
38,234
Power
819$
Sentiment
8.72
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
Paraguay 1 8.00 0.06% +0% 7,132,538 4,009 $38,000 21$
Bolivia 1 8.00 0.06% +0% 11,673,021 6,915 $40,000 24$
Spain 1 9.00 0.05% +0% 46,754,778 25,619 $1,400,000 767$
Cabo Verde 1 9.00 0.30% +0% 555,987 1,690 $2,100 6$
Totals 4 66,116,324 38,233 $1,480,100 818$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Cabo Verde Cabo Verde: Alberto Ascherio was awarded the Breakthrough Prize for his significant contributions to the understanding of multiple sclerosis. 9

Expresso das Ilhas – Cape Verdean newspaper & portal: Descobertas sobre esclerose múltipla recompensadas com 'Óscar da Ciência'

Bolivia Bolivia: Alberto Ascherio is a professor of Epidemiology at Harvard University who commented on the study's findings. 8

El Deber: Un ensayo fortuito constata la eficacia de la vacuna del herpes frente a la demencia

Paraguay Paraguay: Alberto Ascherio is a professor of Epidemiology at Harvard University who commented on the potential role of viral infections in Alzheimer's disease. 8

ABC Color – leading Paraguayan newspaper, est. 1967: Vacuna del herpes sería efectiva contra la demencia - Ciencia

Spain Spain: Alberto Ascherio, a professor of epidemiology at Harvard University, describes the study as valuable and the most rigorous published on the topic. 9

El País: Vacunarse contra el herpes zóster podría reducir el riesgo de sufrir demencia | Salud y bienestar